Aclaris Therapeutics (ACRS) EBT Margin Growth (5y) (2022 - 2026)
Aclaris Therapeutics (ACRS) EBT Margin Growth (5y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Aclaris Therapeutics | 705.88 Mn | 705.88 Mn | 1.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 151,633.00 |
| Dec 31, 2025 | 695,631.00 |
| Sep 30, 2025 | 22,104.00 |
| Jun 30, 2025 | -48,817.00 |
| Mar 31, 2025 | -16,759.00 |
| Dec 31, 2024 | 44,909.00 |
| Sep 30, 2024 | 220,098.00 |
| Jun 30, 2024 | 821,891.00 |
| Mar 31, 2024 | 401,899.00 |
| Dec 31, 2023 | 60,624.00 |
| Sep 30, 2023 | 223,107.00 |
| Jun 30, 2023 | -84,835.00 |
| Mar 31, 2023 | 238,850.00 |
| Dec 31, 2022 | -1,516.00 |
| Sep 30, 2022 | 571,465.00 |